Advanced Wound Care.
Guided by Science.
Quorit brings together clinical understanding, biomaterial science and research-driven innovation to develop wound-care solutions for diverse clinical needs.
"Because every wound is different. Effective care begins with understanding it."
Native triple-helix architectures supporting microvascular perfusion, fibroblast migration, and cellular homeostasis.
From Understanding the Wound to Informed Wound Management
UNDERSTAND
Understand the wound and its clinical context thoroughly.
ASSESS
Systematically assess the wound bed, tissue, and exudate.
IDENTIFY
Identify physiological and microbial barriers to healing.
SELECT
Select an appropriate targeted wound-care approach.
REVIEW
Review empirical clinical evidence and progress metrics.
Advanced Wound Care.
Guided by Science.
The foundational premise governing our biomaterial synthesis, clinical trials, and bedside implementation.
Quorit is an advanced wound-care brand dedicated to the science of wound healing. We combine clinical understanding, biomaterial science and research-driven innovation to develop wound-care solutions for diverse clinical needs. Our approach begins with understanding the wound and the factors that may influence its progression, followed by the selection of appropriate solutions across the healing journey.
From biomimetic-based technologies to advanced wound dressings and supportive wound-care solutions, Quorit brings together a comprehensive portfolio designed around the evolving requirements of modern wound management.
Because every wound is different. Effective care begins with understanding it.
CLINICAL UNDERSTANDING
Rooted in patient biology and systemic etiology.
BIO MATERIAL SCIENCE
Engineered biomimetic extracellular scaffolds.
RESEARCH-DRIVEN INNOVATION
Validating regenerative pathways empirically.
Ask What Is Driving It.
A wound cannot be understood by appearance alone. Start by understanding the cause, the patient and the wound itself.
CAUSE / ETIOLOGY
Underlying pathology determines biological progression and treatment constraints.
- Diabetic Neuro-ischemic
- Venous Insufficiency
- Arterial Occlusive
- Pressure / Shear Injury
- Traumatic & Surgical Wounds
- Other Atypical Ulcerations
PATIENT FACTORS
Systemic physiology dictates cellular repair capacity and immune resilience.
- Vascular Perfusion & ABI
- Diabetes & Glycemic Control
- Nutritional Albumin / Protein
- Mobility & Mechanical Offloading
- Immunosuppression & Comorbidities
WOUND FACTORS
Immediate microenvironmental conditions impeding or fostering re-epithelialization.
- Anatomical Location & Depth
- Surface Area & Chronicity
- Pain Score & Quality
- Exudate Viscosity & Volume
- Peri-Wound Maceration / Erythema
Why Do Some Wounds Fail to Progress?
In a healthy body, a wound follows a well-orchestrated path to healing. But sometimes, this journey is disrupted. Several biological and clinical factors can create barriers, keeping the wound trapped in a cycle of non-healing.
EXCESS PROTEASE ACTIVITY
Persistent degradation of extracellular matrix & growth factors.
BIOFILM & MICROBIAL PERSISTENCE
Protected microbial communities resisting host defenses.
PERSISTENT INFLAMMATION
Chronic pro-inflammatory state trapping tissue repair.
IMPAIRED PERFUSION & HYPOXIA
Suboptimal microvascular delivery and oxygenation.
SYSTEMIC & LOCAL FACTORS
Metabolic dysregulation, pressure, and nutritional deficit.
TIME: A Systematic Approach to Wound Assessment
How Do We Know What Is Holding the Wound Back? A systematic wound assessment helps turn a complex wound into identifiable clinical problems.
"What Is in the Wound Bed?"
Is the wound bed ready to heal?
LOOK FOR:
Clinical Purpose: Remove physical barriers, devitalized matrix, and bacterial niches to create a viable, vascularized wound bed capable of cellular adhesion.
Non-viable slough and fibrinous eschar clearance allows native granulation tissue and microvascular buds to colonize.
What Did We Find?
Translating discrete clinical assessment parameters into an iterative therapeutic workflow.
| TIME Parameter | Identified Clinical Finding | Therapeutic Objective | Quorit Intervention Focus |
|---|---|---|---|
| T — Tissue | Non-viable / deficient tissue, slough, or necrotic matrix | Debridement, clearance, and healthy granulation bed creation | Bioactive Scaffolds / Autolytic Dressings |
| I — Infection / Inflammation | Persistent inflammation / recalcitrant microbial burden / biofilm | Biofilm disruption, microbial reduction, protease attenuation | Antimicrobial & Anti-inflammatory Matrices |
| M — Moisture | Too dry / too wet / uncontrolled corrosive exudate | Moisture balance, peri-wound protection, exudate absorption | QuoroFoam® & QuoroPad® Exudate Systems |
| E — Edge | Non-advancing / undermined / hyperkeratotic wound margins | Epithelial advancement, contact guidance, wound contracture | QuoroSkin® Native Structural Scaffolds |
ASSESS
Systematic examination using TIME and systemic diagnostic indicators.
IDENTIFY
Isolate active barriers: bioburden, protease excess, or desiccation.
ADDRESS
Deploy tailored biomaterials, scaffolds, and protective dressings.
REASSESS
Continuously measure epithelial migration rate and tissue quality.
Solutions Designed Around Wound-Management Needs
Following systematic assessment, Quorit brings together advanced wound-care solutions designed around the evolving requirements of modern wound management.
QUOROGEL®
BIOACTIVE BIOMATERIAL MATRIX
Engineered amorphous extracellular hydrogel facilitating autolytic debridement while stabilizing cellular adhesion factors.
QuoroSkin®, QuoroSkin-D®
NATIVE COLLAGEN SOLUTIONS
Type-I bio-compatible collagen matrices providing physical templates for fibroblast migration and binding excessive destructive MMPs.
QuoroFoam®, QuoroPad®
ADVANCED WOUND DRESSINGS
Also featuring QuoroGuard® and Silicone variants. Engineered for vertical fluid lock, protecting delicate peri-wound margins.
X-Scar®
SCAR MANAGEMENT SYSTEM
Medical-grade silicone polymer matrix mitigating hypertrophic scarring and supporting tension-free epidermal maturation post-closure.
Evidence That Informs Clinical Practice
Rigorous, peer-reviewed evaluation of biomaterial scaffolds across standardized preclinical and clinical study cohorts. Conservative data integrity without unsupported extrapolation.
Recalcitrant Venous Ulcer Trajectory
Evaluation of bioactive collagen matrix application in wounds unresponsive to conventional standard of care over a multi-week observation cycle.
MMP Sequestration & Hydrogel Affinity
Quantitative enzymatic assay measuring competitive sacrificial binding of active MMP-2 and MMP-9 against intact structural native collagen.
ISO 10993 Biocompatibility Matrix
Comprehensive biological evaluation assessing cytotoxicity, sensitization, and intracutaneous reactivity across all Quorit dermal polymers.
Every Wound Is Different.
Understanding Comes First.
Explore the science, assessment framework and wound-care solutions behind Quorit. Connect with our medical affairs division for clinical evaluations.